In the chemorelapsed group instead, expression data were then again similar to those from above mentioned study with a shift to more highly positive SCLC cases [(53.3%, 16/30) vs. 46.6% (14/30) DLL3 low expressing samples]. The gene discussed is DLL3; the disease is small cell lung carcinoma.